A number of environmental substances have the ability to decrease white blood cells, which are the pillars of our immune defense.1
As a biochemist, Dr. Mirko Beljanski knew that for any cell to divide, it requires short RNAs, which act as specific initiators of cell proliferation. These RNA fragments are essential to our proper physiological functioning.2, 3
Dr. Mirko Beljanski was able to develop short fragments of initiating RNA which are involved in the genesis of leukocyte (white blood cells) and megakaryocyte (platelet) lineages, similar to those that any healthy organism produces physiologically. These initiators specifically stimulate the multiplication of these cells. They have no effect on other cells. They simply trigger the organism to produce, naturally and in physiological proportions, white blood cells and platelets, so necessary for our immune defense and blood coagulation.4 5 6
Using non-pathogenic strains of the bacterium Escherichia Coli K12, Dr. Mirko Beljanski developed a natural method for preparing these RNA fragments.
10 doses of 20 mg of ribonucleic extract of Escherichia Coli K-12.
As a dietary supplement, take one dose every two days, or as directed by a healthcare practitioner. Allow contents to melt under the tongue in the morning on an empty stomach. Do not exceed the recommended daily dosage.
Our formulation does not contain any known allergens. However, while our Manufacturers take steps to minimize the risk of any cross contact, we cannot guarantee that any of our products do not contain trace amounts of, and are safe for consumers with peanut, tree nut, soy, milk, egg, shellfish or wheat allergies.
The use of ReaLBuild® is not recommended for people following a treatment with Benzodiazepine or when an aplasia is sought in the case of certain cancer treatments. Regular intake of magnesium is recommended.
1 D. BRAUN, J.E. HARRIS, “Modulation of the Immune Response by Chemotherapy”, Pharma health c. Ther 14, 89-122 (1981)
2 G.K. KRIMBLE, “Essential and Conditionally-Essential Nutrients in Clinical Nutrition”. Nutrition Research Reviews, (1993) 6, 97-119.
3 W.C. FANSLOW, A.D. KULKARNI, C.T. VAN BUREN, F.G. RUDOLPH, “Effect of Nucleotide Restriction and Supplementation on Resistance to Experimental Murine Candidiasis”. Journal of Parenteral and Enteral Nutrition, Vol. 12, No 1, (1998) pp 49-52.
4 M. BELJANSKI, M. PLAWECKI, P. BOURGAREL, M. S. BELJANSKI, "Nouvelles substances (R.L.B.) actives dans la leucopoïese et la formation des plaquettes ". Bull. Acad. Nat. Med., 1978, 162, Volume n°6, pp. 475-781.
5 M. BELJANSKI, " Overview: BLRs as Inducers of In Vivo Leucocyte and Platelet Genesis ". Deutsche Zeitschrift für Onkologie, 24, 2, 1992, pp. 41-46.
6 M. BELJANSKI, " The Regulation of DNA Replication and Transcription. The Role of Trigger Molecules in Normal and Malignant Gene Expression ". EVI Liberty (2003), (First Edition: Experimental Biology and Medicine, vol.8, Karger -1983), pp. 11-15